These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 9011577)

  • 1. Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes.
    Garin MC; James RW; Dussoix P; Blanché H; Passa P; Froguel P; Ruiz J
    J Clin Invest; 1997 Jan; 99(1):62-6. PubMed ID: 9011577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of physical activity on lipid levels in a population-based sample of men with and without the Arg192 variant of the human paraoxonase gene.
    Sentí M; Aubó C; Elosua R; Sala J; Tomás M; Marrugat J
    Genet Epidemiol; 2000 Mar; 18(3):276-86. PubMed ID: 10723110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum paraoxonase activity and paraoxonase gene polymorphism in type 2 diabetic patients with or without vascular complications.
    Letellier C; Durou MR; Jouanolle AM; Le Gall JY; Poirier JY; Ruelland A
    Diabetes Metab; 2002 Sep; 28(4 Pt 1):297-304. PubMed ID: 12442067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paraoxonase 1 192 Gln/Arg gene polymorphism and cerebrovascular disease: interaction with type 2 diabetes.
    Koch M; Hering S; Barth C; Ehren M; Enderle MD; Pfohl M
    Exp Clin Endocrinol Diabetes; 2001; 109(3):141-5. PubMed ID: 11409295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paraoxonase-1 promoter haplotypes and serum paraoxonase: a predominant role for polymorphic position - 107, implicating the Sp1 transcription factor.
    Deakin S; Leviev I; Brulhart-Meynet MC; James RW
    Biochem J; 2003 Jun; 372(Pt 2):643-9. PubMed ID: 12639220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myeloperoxidase and paraoxonase-1 in type 2 diabetic patients.
    Jornayvaz FR; Brulhart-Meynet MC; James RW
    Nutr Metab Cardiovasc Dis; 2009 Nov; 19(9):613-9. PubMed ID: 19201174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low paraoxonase activity in type II diabetes mellitus complicated by retinopathy.
    Mackness B; Durrington PN; Abuashia B; Boulton AJ; Mackness MI
    Clin Sci (Lond); 2000 Mar; 98(3):355-63. PubMed ID: 10677395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of myocardial infarction associated with Gln/Arg 192 polymorphism in the human paraoxonase gene and diabetes mellitus. The REGICOR Investigators.
    Aubó C; Sentí M; Marrugat J; Tomás M; Vila J; Sala J; Masiá R
    Eur Heart J; 2000 Jan; 21(1):33-8. PubMed ID: 10610741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The paraoxonase PON1 promoter polymorphism C(-107)T is associated with increased serum glucose concentrations in non-diabetic patients.
    Leviev I; Kalix B; Brulhart Meynet MC; James RW
    Diabetologia; 2001 Sep; 44(9):1177-83. PubMed ID: 11596674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of alcohol dehydrogenase 1C polymorphism on the alcohol-cardiovascular disease association (from the Framingham Offspring Study).
    Djoussé L; Levy D; Herbert AG; Wilson PW; D'Agostino RB; Cupples LA; Karamohamed S; Ellison RC
    Am J Cardiol; 2005 Jul; 96(2):227-32. PubMed ID: 16018848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paraoxonase polymorphisms are not associated with cardiovascular risk in renal transplant recipients.
    Hasselwander O; Savage DA; McMaster D; Loughrey CM; McNamee PT; Middleton D; Nicholls DP; Maxwell AP; Young IS
    Kidney Int; 1999 Jul; 56(1):289-98. PubMed ID: 10411705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Relationship between paraoxonase 1 55 Met/Leu, paraoxonase 2 148 Ala/Gly genetic polymorphisms and coronary artery disease].
    Chi DS; Ling WH; Ma J; Xia M; Hou MJ; Wang Q; Zhu HL; Tang ZH; Yu XP
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Jun; 23(3):289-93. PubMed ID: 16767666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inverse correlation of serum paraoxonase and homocysteine thiolactonase activities and antioxidant capacity of high-density lipoprotein with the severity of cardiovascular disease in persons with type 2 diabetes mellitus.
    Lakshman MR; Gottipati CS; Narasimhan SJ; Munoz J; Marmillot P; Nylen ES
    Metabolism; 2006 Sep; 55(9):1201-6. PubMed ID: 16919539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High plasma C-reactive protein (CRP) is related to low paraoxonase-I (PON-I) activity independently of high leptin and low adiponectin in type 2 diabetes mellitus.
    Dullaart RP; de Vries R; Sluiter WJ; Voorbij HA
    Clin Endocrinol (Oxf); 2009 Feb; 70(2):221-6. PubMed ID: 18505467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Further evidence for an association of the paraoxonase 1 (PON1) Met-54 allele with Parkinson's disease.
    Carmine A; Buervenich S; Sydow O; Anvret M; Olson L
    Mov Disord; 2002 Jul; 17(4):764-6. PubMed ID: 12210872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Gln-Arg191 polymorphism of the human paraoxonase gene (HUMPONA) is not associated with the risk of coronary artery disease in Finns.
    Antikainen M; Murtomäki S; Syvänne M; Pahlman R; Tahvanainen E; Jauhiainen M; Frick MH; Ehnholm C
    J Clin Invest; 1996 Aug; 98(4):883-5. PubMed ID: 8770857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paraoxonase/arylesterase ratio, PON1 192Q/R polymorphism and PON1 status are associated with increased risk of ischemic stroke.
    Can Demirdöğen B; Türkanoğlu A; Bek S; Sanisoğlu Y; Demirkaya S; Vural O; Arinç E; Adali O
    Clin Biochem; 2008 Jan; 41(1-2):1-9. PubMed ID: 17920578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement factor H gene polymorphism and risk of cardiovascular disease in end-stage renal disease patients.
    Buraczynska M; Ksiazek P; Zukowski P; Benedyk-Lorens E; Orlowska-Kowalik G
    Clin Immunol; 2009 Aug; 132(2):285-90. PubMed ID: 19428307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paraoxonase 1 (PON1) gene polymorphisms and Parkinson's disease in a Finnish population.
    Clarimon J; Eerola J; Hellström O; Tienari PJ; Singleton A
    Neurosci Lett; 2004 Sep; 367(2):168-70. PubMed ID: 15331145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human paraoxonase gene polymorphisms and coronary artery disease risk.
    Mendonça MI; Dos Reis RP; Freitas AI; Sousa AC; Pereira A; Faria P; Gomes S; Silva B; Santos N; Serrão M; Ornelas I; Freitas S; Araújo JJ; Brehm A; Cardoso AA
    Rev Port Cardiol; 2008 Dec; 27(12):1539-55. PubMed ID: 19280995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.